Results 231 to 240 of about 5,558,618 (260)

Site-Specific Hydrogen-Deuterium Exchange Mass Spectrometry for Deep Explorations of Dynamic Shifts in Protein-Drug Interactions. [PDF]

J Am Chem Soc
Anacleto J, Wolf E, Ackloo S, Arrowsmith C, LeBlanc Y, Lento C, Wilson DJ.   +6 more
europepmc   +1 more source

Thalamo‐Lesional Connectivity Signatures of Bilateral Tonic–Clonic Seizures in Focal Cortical Dysplasia‐Related Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Focal cortical dysplasia (FCD) is the most common etiology of drug‐resistant epilepsy in children. Focal to bilateral tonic–clonic seizures (FBTCS) mark a high risk of drug‐resistant epilepsy and involve thalamocortical circuitry in their generation and propagation.
Hua Xie, Xiaotong Li, Venkata Sita Priyanka Illapani, Leigh N. Sepeta, Jason Schroeder, Chima O. Oluigbo, Madison M. Berl, William D. Gaillard, Nathan T. Cohen   +8 more
wiley   +1 more source

Nontherapeutic INR After Hospital Discharge: A Repeated-Measures Analysis of Warfarin-Treated Patients and Potential Drug-Drug Interactions. [PDF]

Clin Pract
Methaset K, Kosuma P, Jedsadayanmata A.
europepmc   +1 more source

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether myelin‐sensitive quantitative MRI reveals microstructural abnormalities in normal‐appearing cortex (NACtx) in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), indicating that conventional MRI underestimates remission residual cortical injury.
Valentina Camera, Agnese Tamanti, Silvia Messina, Nicola Dall'Osto, Teresa Maltempo, Stefano Ziccardi, Matteo Foschi, Maria Grazia Piscaglia, Diana Ferraro, Francesco Crescenzo, Francesca Rossi, Albulena Bajrami, Sabrina Marangoni, Damiano Marastoni, Francesca Benedetta Pizzini, Maria Isabel Leite, Roberta Magliozzi, Patrick Waters, Massimiliano Calabrese, Jacqueline Palace, Ruth Geraldes   +20 more
wiley   +1 more source

Synergistic Effects of Inflammation and Drug Interactions on <i>CYP3A5*3/*3</i> Phenoconversion in Antipsychotic Metabolism. [PDF]

Pharmaceutics
Kőhalmy K, Borthakur A, Porrogi P.
europepmc   +1 more source

Food-drug interactions of novel drugs used in cardiologic and diabetic patients - a PRISMA scoping review. [PDF]

Front Pharmacol
Pawłowska I, Kuźbicka K, Kowalczys A, Pawłowski L, Kocić I.   +4 more
europepmc   +1 more source

Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants. [PDF]

Clin Transl Sci
Chen J, Wu J, Song Y, Li J, Li L, Li L, Kong Y, Wu X, Yin H, Hou M, Wang B, Gao Q, Li R, Wu L, Xue W, Dong R.   +15 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]

CPT Pharmacometrics Syst Pharmacol
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc   +1 more source

Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence. [PDF]

Curr Oncol Rep
Yiu CH, Winardi K, Lu CY.
europepmc   +1 more source

In a bind: a quality improvement project for reducing fluoroquinolones drug-drug interactions with multivalent cations. [PDF]

JAC Antimicrob Resist
Siegrist EA, Pan SJ, Alkozah M, Doan D, White BP.   +4 more
europepmc   +1 more source